Alpine Global Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,324
Closed -$654K 605
2021
Q4
$654K Buy
+6,324
New +$732K 0.1% 292
2020
Q3
Sell
-9,693
Closed -$889K 365
2020
Q2
$889K Buy
9,693
+4,665
+93% +$447K 0.16% 98
2020
Q1
$453K Buy
+5,028
New +$535K 0.09% 125
2017
Q2
Sell
-7,563
Closed -$609K 260
2017
Q1
$609K Buy
+7,563
New +$591K 0.16% 111
2015
Q3
Sell
-12,292
Closed -$911K 513
2015
Q2
$911K Sell
12,292
-6,597
-35% -$504K 0.15% 110
2015
Q1
$1.47M Buy
+18,889
New +$1.43M 0.48% 41
2014
Q2
Sell
-4,280
Closed -$263K 206
2014
Q1
$263K Buy
+4,280
New +$249K 0.23% 90

Other funds holding MDT

Alpine Global Management's MDT Position: Q1 2022 in Review

Alpine Global Management sold out of Medtronic (MDT) in Q1 2022, closing a stake of 6,324 shares — an estimated $654K sold.

Alpine Global Management first reported a position in MDT in Q1 2014 and held it in 7 quarters. The position peaked at $1.47M in Q1 2015. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Alpine Global Management reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • Alpine Global Management sold 6,324 Medtronic shares in Q1 2022, an estimated $654K.
  • Alpine Global Management first reported a position in Medtronic in Q1 2014 and held it in 7 quarters.
  • Alpine Global Management's Medtronic position peaked at $1.47M in Q1 2015.
  • 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Alpine Global Management's 13F filing for Q1 2022, filed 13 May 2022.